ASCO News: Kidney Cancer Drug Delays Ovarian Cancer Relapse
ASCO News: Kidney Cancer Drug Delays Ovarian Cancer Relapse
Research presented at the American Society of Clinical Oncology annual meeting this week suggests that adding the drug pazopanib (trade name Votrient) to standard treatment extends progression-free survival in ovarian … Continued